UPTRAVI
ACTELION · SELEXIPAG
Open FDA's page for this record- Application number
- NDA214275
- Sponsor name
- ACTELION
- Submissions
- Submission type
- SUPPL
- Submission number
- 2
- Submission status
- AP
- Submission status date
- 20260523
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 86052
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/207947Orig1s014; s015; 214275Orig1s002ltr.pdf
- Date
- 20260527
- Type
- Letter
- ID
- 86130
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/207947Orig1s014,s015;214275Orig1s002lbl.pdf
- Date
- 20260911
- Type
- Label
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20210729
- Review priority
- STANDARD
- Submission class code
- TYPE 3
- Submission class code description
- Type 3 - New Dosage Form
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 68248
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214275Orig1s000ltr.pdf
- Date
- 20210802
- Type
- Letter
- ID
- 68260
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214275s000lbl.pdf
- Date
- 20210802
- Type
- Label
- ID
- 69131
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214275Orig1s000TOC.html
- Date
- 20211027
- Type
- Review
- Products
- Product number
- 001
- Reference drug
- Yes
- Brand name
- UPTRAVI
- Reference standard
- Yes
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Active ingredients
- Name
- SELEXIPAG
- Strength
- 1.8MG/VIAL
- Harmonized identifiers (openFDA)
- Application number
- NDA214275
- Brand name
- UPTRAVI
- Generic name
- SELEXIPAG
- Manufacturer name
- Actelion Pharmaceuticals US, Inc.
- Product NDC
- 66215-718, 66215-602, 66215-604, 66215-606, 66215-608, 66215-610, 66215-612, 66215-614, 66215-616, 66215-628, 66215-910, 66215-915
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- SELEXIPAG
- RxCUI
- 1729007, 1729013, 1729027, 1729029, 1729031, 1729033, 1729045, 1729047, 1729051, 1729053, 1729055, 1729057, 1729059, 1729061, 1729063, 1729065, 1729075, 1729076, 2565271, 2565275, 2744282, 2744284, 2744286, 2744288
- SPL ID
- 7c54a125-9778-41f5-b92c-181711e22e06
- SPL set ID
- a7a23b87-f892-4e2c-8e2e-ebf841220f90
- Package NDC
- 66215-602-06, 66215-602-14, 66215-604-06, 66215-606-06, 66215-608-06, 66215-610-06, 66215-612-06, 66215-614-06, 66215-616-06, 66215-628-20, 66215-718-01, 66215-910-14, 66215-915-14
- Nui
- N0000192339, N0000020068
- Pharm class epc
- Prostacyclin Receptor Agonist [EPC]
- Pharm class moa
- Prostacyclin Receptor Agonists [MoA]
- UNII
- 5EXC0E384L
